.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
AstraZeneca
Chubb
Cantor Fitzgerald
Deloitte
Argus Health
Citi
Farmers Insurance
Mallinckrodt
Medtronic

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085128

« Back to Dashboard
NDA 085128 describes ADIPEX-P, which is a drug marketed by Teva and is included in two NDAs. It is available from two suppliers. Additional details are available on the ADIPEX-P profile page.

The generic ingredient in ADIPEX-P is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.

Summary for NDA: 085128

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 085128

Suppliers and Packaging for NDA: 085128

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADIPEX-P
phentermine hydrochloride
TABLET;ORAL 085128 ANDA PD-Rx Pharmaceuticals, Inc. 55289-379 55289-379-30 30 TABLET in 1 BOTTLE, PLASTIC (55289-379-30)
ADIPEX-P
phentermine hydrochloride
TABLET;ORAL 085128 ANDA Teva Select Brands 57844-009 57844-009-00 40 TABLET in 1 BOTTLE (57844-009-00)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength37.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Mallinckrodt
Medtronic
Chubb
Healthtrust
Fish and Richardson
Farmers Insurance
McKesson
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot